My family started Alzheimer's Institute back in 1992 because our grandmother was afflicted with the disease. Out of our own pocket we funded a scientist's work in the field when no other pharma company or bio pharmaceutical was willing to invest. The scientist was and still is a close family friend. Because of his research he discovered Swedish Mutation which led for the first time the medical field to have a mice model to test drugs against and look for a cure. We are very open and in fact have a disease modifying drug starting phase II trials in the clinic that looks to be able to clear beta amyloid. AIA has an ownership in Archer pharmaceuticals which is developing this cure. Unfortunately to get the drug to Phase III trials will cost over $300M. We look to our license as a way to raise funding. But companies like Jackson Labs is not interested in finding a cure but only growing there business similar to the way big government grows. They want to enjoy their big salaries and paid for trips around the country in the cloak of trying to help the field. Furthermore no one at AIA has drawn a salary. What little money AIA does receive goes to funding litigation efforts to let the industry know they can not steal from us and hopefully raise the needed money for next phase development. This is very much a David and Goliath story. Just remember pharma companies are not interested in finding a cure to the disease, because that would destroy their profit structure. They want a drug that has to continually be purchased thereby increasing their stock price. We hope with careful consideration you might think deferentially about what might really be happening behind the scenes. Perhaps even to help support our effort to finding a cure. Sincerely, AIA Foundation

Dear failedlogic, My family started Alzheimer's Institute back in 1992 because our grandmother was afflicted with the disease. Out of our own pocket we funded a scientist's work in the field when no other pharma company or bio pharmaceutical was willing to invest. The scientist was and still is a close family friend. Because of his research he discovered Swedish Mutation which led for the first time the medical field to have a mice model to test drugs against and look for a cure. We are very open and in fact have a disease modifying drug starting phase II trials in the clinic that looks to be able to clear beta amyloid. AIA has an ownership in Archer pharmaceuticals which is developing this cure. Unfortunately to get the drug to Phase III trials will cost over $300M. We look to our license as a way to raise funding. But companies like Jackson Labs is not interested in finding a cure but only growing there business similar to the way big government grows. They want to enjoy their big salaries and paid for trips around the country in the cloak of trying to help the field. Furthermore no one at AIA has drawn a salary. What little money AIA does receive goes to funding litigation efforts to let the industry know they can not steal from us and hopefully raise the needed money for next phase development. This is very much a David and Goliath story. Just remember pharma companies are not interested in finding a cure to the disease, because that would destroy their profit structure. They want a drug that has to continually be purchased thereby increasing their stock price. We hope with careful consideration you might think deferentially about what might really be happening behind the scenes. Perhaps even to help support our effort to finding a cure. Sincerely, AIA Foundation

Dear Mastermind, My family started Alzheimer's Institute back in 1992 because our grandmother was afflicted with the disease. Out our own pocket we funded a scientists work in the field when no other pharma company or bio pharmaceutical was willing to invest. The scientist was and still is a close family friend. Because of his research he discovered Swedish Mutation which led for the first time the medical field to have a mice model to test drugs against and look for a cure. We are very open and in fact have a disease modifying drug starting phase II trials the clinic that looks to be able to clear beta amyloid. AIA has an ownership in Archer pharmaceuticals which is developing this cure. Unfortunilty to get the drug to Phase III trials will cost over $300M. We look to our license as a way to raise funding. But companies like Jackson Labs is not interested in finding a cure but only growing there business similar to the way big government grows. They want to enjoy their big salaries and paid for trips around the country in the cloak of trying to help the field. Furthermore no one at AIA has drawn a salary. What little money AIA does receive goes to funding litigation efforts to let the industry no they can not steal from us. This is very much a David and Goliath story. We hope with careful consideration you might think deferentially about what might really be happening behind the scenes. Sincerely, AIA Foundation